Clinical Trial for Ovarian Cancer (OvaRex®)
NCT00050375 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 354
Last updated 2007-12-18
Summary
This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.
Conditions
Interventions
- DRUG
-
oregovomab
Sponsors & Collaborators
-
Unither Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00075543 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer
NCT00877253 ·Status: COMPLETED ·Phase: PHASE1
-
Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer
NCT00562185 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer
NCT00791778 ·Status: COMPLETED ·Phase: PHASE2
-
Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer
NCT00466986 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer
NCT00846612 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
NCT00179712 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
NCT00129727 ·Status: COMPLETED ·Phase: PHASE2
-
Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
NCT04938583 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
NCT00005046 ·Status: COMPLETED ·Phase: PHASE1
-
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
NCT01616303 ·Status: COMPLETED ·Phase: PHASE2
-
Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer
NCT01253681 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT02389985 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
NCT00051948 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
NCT01220154 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
NCT01219777 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
NCT00050414 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
NCT00179725 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
NCT01124435 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
NCT00003644 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer
NCT01276548 ·Status: COMPLETED ·Phase: PHASE2
-
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
NCT00504257 ·Status: COMPLETED ·Phase: PHASE2
-
Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
NCT00005836 ·Status: COMPLETED ·Phase: PHASE2